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Global energy demand and environmental concerns have stimu-
lated increasing efforts to produce carbon-neutral fuels directly
from renewable resources. Microbially derived aliphatic hydrocar-
bons, the petroleum-replica fuels, have emerged as promising
alternatives to meet this goal. However, engineering metabolic
pathways with high productivity and yield requires dynamic re-
distribution of cellular resources and optimal control of pathway
expression. Here we report a genetically encoded metabolic switch
that enables dynamic regulation of fatty acids (FA) biosynthesis in
Escherichia coli. The engineered strains were able to dynamically
compensate the critical enzymes involved in the supply and con-
sumption of malonyl-CoA and efficiently redirect carbon flux to-
ward FA biosynthesis. Implementation of this metabolic control
resulted in an oscillatory malonyl-CoA pattern and a balanced me-
tabolism between cell growth and product formation, yielding
15.7- and 2.1-fold improvement in FA titer compared with the
wild-type strain and the strain carrying the uncontrolled metabolic
pathway. This study provides a new paradigm in metabolic engi-
neering to control and optimize metabolic pathways facilitating the
high-yield production of other malonyl-CoA–derived compounds.
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Agrand challenge in synthetic biology is to move the design ofbiomolecular circuits from purely genetic constructs toward
systems that integrate different levels of cellular complexity, in-
cluding regulatory networks and metabolic pathways (1). Despite
the fact that a large volume of regulatory architectures and
motifs has been discovered (2, 3), little has been accomplished in
pathway engineering to improve cellular productivity and yield
by exploiting dynamic pathway regulation and metabolic control
(4). One essential part in implementing synthetic metabolic
control in pathway engineering is to engineer novel metabolite
sensors with desired input–output relationships. For example,
Liao et al. (5–7) have designed and applied a regulatory circuit
that can sense the glycolytic pathway hallmark metabolite acetyl-
phosphate to control the lycopene biosynthetic pathway (5) and
generate oscillatory gene expression (6) as well as achieve arti-
ficial cell–cell communication (7). Dahl et al. (8) have used stress-
response promoters to improve farnesyl pyrophosphate production,
and Tsao et al. (9) have rewired the Escherichia coli native quorum-
sensing regulon for autonomous induction of recombinant proteins.
Traditional metabolic engineering is largely focused on the
overexpression of rate-limiting steps (10), deletion of competing
pathways (11), managing ATP (12, 13), and balancing redox and
precursor metabolites (13). Although these approaches have
been shown to be effective in improving cellular productivity and
yield, the engineered strains are often incapable of dynamically
controlling gene expression and are susceptible to environmental
perturbations. For example, precursor flux improvement by
overexpression of heterologous enzymes may not be accommo-
dated by downstream pathways; the buildup of toxic inter-
mediates may elicit stress response that compromises cell
viability and pathway productivity (8, 14). On the other
hand, inducible or constitutive promoters are susceptible to
environmental perturbations: any deviations from the optimal
state would impair cell productivity and yield (15). Ideally, the
cell would sense a critical intermediate accumulating inside the
cell and trigger the expression of downstream pathways that
convert this intermediate to the final product. From a control
theory perspective, there is a pressing need to engineer robust
cells that can automatically adjust pathway expression and adapt
the metabolic activity to the changing environment (16).
Recent efforts in microbial biofuel production hinge upon
constructing efficient metabolic pathways to produce a variety of
fatty acids (FA)-based fuels (17–23). To date, most of the work
has taken a static perspective to coordinate the expression of
enzymes and optimize production titer and yield, including mo-
dification of plasmid copy number (24), promoter strength (25,
26), and combinations of these strategies (21, 27). Further pro-
duction improvement calls for novel approaches that rewire
transcriptional control mechanisms and achieve dynamic path-
way regulation. Here we present a genetically encoded metabolic
switch that enables dynamic regulation of both the malonyl-CoA
source pathway and the malonyl-CoA sink pathway. Engineering
hybrid promoter–transcriptional regulator interactions led to the
construction of two malonyl-CoA sensors that exhibit opposing
transcriptional activities. Proper balancing of the transcriptional
activity of the malonyl-CoA–upregulating promoter and the
malonyl-CoA–downregulating promoter resulted in an integrated
malonyl-CoA switch rendering bistable gene expression pattern.
When this synthetic malonyl-CoA switch was implemented to
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control fatty acids production, the engineered strain could better
balance the trade-off between cell growth and product for-
mation and demonstrated superior FA production profile.
Results and Discussion
Characterization of Malonyl-CoA Sensors. Malonyl-CoA is the rate-
limiting precursor involved in the chain elongation reaction of
a range of value-added pharmaceuticals and biofuels (28, 29).
Development of malonyl-CoA–responsive sensors holds great
promise in overcoming critical pathway limitations and opti-
mizing production titers and yields (30). Small-molecule–
responsive transcriptional factors were generally rewired to in-
teract with the core sequence (−35 or −10 region) of a certain
promoter, offering great potential for transcriptional biosensing
and metabolic control (31). Based on the findings of Schujman
(32, 33), FapR is a putative transcription repressor that specifi-
cally senses malonyl-CoA and regulates gene expression in the
Bacillus subtilis fatty acids biosynthetic pathway. By in-
corporating the B. subtilis transcription factor FapR and the
cis-regulatory element fapO, our previous efforts (30) have
identified a T7-based malonyl-CoA sensor exhibiting malonyl-
CoA–dependent transcriptional activity (Fig. 1A). This T7-based
malonyl-CoA sensor was shown to be able to respond to a broad
range of intracellular malonyl-CoA (from 0.1 to 1.1 nmol/mgDW,
SI Appendix, Fig. S1).
Next we engineered another malonyl-CoA sensor consisting of
the E. coli native promoter pGAP (Fig. 1B). This is a σ70-
dependent promoter that uses the E. coli RNA polymerase
(RNAP) to initiate gene transcription (34). Surprisingly, the
transcriptional activity of the pGAP-based malonyl-CoA sensor
(Fig. 1D) was markedly different from that of the T7-based
malonyl-CoA sensor (SI Appendix, Fig. S1). Contrary to our
expectation that FapR would act as a transcriptional repressor,
gene expression from the pGAP promoter was significantly in-
creased due to the expression of FapR (Fig. 1D). For example,
gene expression was increased almost sevenfold in the sensor
construct compared with the control construct that is devoid of
FapR expression (Fig. 1C). Gene expression in the control
constructs that are devoid of FapR expression remained rela-
tively constant at different levels of malonyl-CoA (Fig. 1C). This
led us to hypothesize that FapR would act as a regulator that
activates gene expression from pGAP promoter. Consistent with
this assumption, increased malonyl-CoA resulted in decreased
gene expression in pGAP promoter (Fig. 1D), which could be
ascribed to the fact that malonyl-CoA would disrupt the FapR–
pGAP–RNAP interaction and thus deactivate the gene expres-
sion. In addition, gene expression in the sensor construct was
Fig. 1. Construction of malonyl-CoA sensors using dual transcriptional regulator FapR. (A) Structure of T7-based malonyl-CoA sensor. T7, bacteriophage T7
promoter; fapO, FapR repressor-binding site; eGFP, enhanced green fluorescence protein (reporter); T7_ter, T7 terminator; fapR, B. subtilis fatty acids
pathway transcriptional regulator. Blunt-end arrows denote repression. (B) Structure of pGAP-based malonyl-CoA sensor. UAS, upstream activation sequence;
pGAP, E. coli pGAP promoter; n × fapO, tandem copies of FapR repressor-binding site (n denotes the number of fapO sites); rrnB, E. coli transcriptional
terminator. Pointed arrows indicate activation. (C) Gene expression from pGAP promoter that is devoid of FapR remained relatively constant at different
levels of malonyl-CoA. (D) FapR-activated pGAP transcriptional activity was downregulated by increasing levels of malonyl-CoA. The sensor construct carries
one copy of fapO downstream of the pGAP promoter. (E) Time-dependent gene expression dynamics of pGAP promoter with tandem copies of fapO (n = 0, 1,
2, 3, 5, 8, 13, and 21). (F) Tuning the dynamic range of pGAP-based malonyl-CoA sensor by adding different numbers of fapO. Malonyl-CoA deactivates the
transcriptional activity of the pGAP-based sensor. Negative control is the sensor construct devoid of FapR expression.
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almost restored to the level of the control construct when
malonyl-CoA was increased to above 1 nmol/mgDW. We also
tested the responsiveness of other E. coli native promoters
(arabinose-induced pBAD and lactose-induced pTrc) with co-
expression of FapR, but no activation effects were found in these
two promoters.
Following this assumption, we turned to investigate how FapR
would interact with pGAP. We arranged in tandem multiple
copies of fapO (n = 0, 1, 2, 3, 5, 8, 13, and 21) between the pGAP
promoter and the reporter gene with the expectation that in-
creasing the number of FapR-binding sites would strengthen the
transcriptional activation. Contrary to our expectations, gene
expression from the pGAP promoter was decreased by in-
creasing the number of fapO sites inserted onto the promoter
region (Fig. 1E). This behavior could be the result of the pres-
ence of repeated sequence spacers that increased the distance of
the promoter from the structural gene (35). Surprisingly, the
sensor construct devoid of any FapR-binding site (n = 0, Fig. 1E)
exhibited the strongest gene activation, leading us to hypothesize
that FapR binds with the pGAP at a region other than the fapO
site. Naturally, we opted to search for possible FapR-binding
sites within the adjacent region of pGAP promoter. The pGAP
promoter, which carries multiple transcriptional factor-binding
sites, confers on E. coli the ability to produce high levels of the
essential glycolysis enzyme glyceraldehyde-3-phosphate de-
hydrogenase under various growth conditions (36). Using
a computational toolbox that predicts transcriptional factor-
binding sites (37), we identified an activation sequence upstream
of the pGAP promoter that could potentially interact with FapR.
To physically validate that FapR interacts with this upstream
activation sequence (UAS), we performed Surface Plasmon
Resonance (SPR) analysis (38, 39) with purified FapR protein
and biotinylated synthetic oligos (fapO and UAS) as testing
subjects (SI Appendix, Figs. S2 and S3). SPR analysis revealed
that FapR has a comparable binding affinity toward UAS (KD =
7.2 × 10−7 M) as opposed to the binding affinity between FapR
and fapO (1.2 × 10−7 M) (SI Appendix, Table S1). Deletion of
this UAS sequence completely eliminated the transcriptional
activation (SI Appendix, Fig. S4), thus confirming our assumption
that FapR binds with UAS sequence and activates gene ex-
pression from pGAP promoter.
Precise control and regulation of heterologous pathway ex-
pression requires the engineering of molecular sensors that span
across a wide range of gene expression dynamics. Generally, the
desired transcriptional dynamics could be tuned by engineering
transcriptional factor and promoter interactions (40). By in-
corporating different copy numbers of fapO, the absolute pro-
moter activity of the pGAP promoter was decreased by 35-fold
from 350 F/min/OD in the sensor with no fapO sites (n = 0) to
10 F/min/OD in the sensor with 21 copies of fapO (n = 21) (Fig.
1F). All of the sensors exhibited malonyl-CoA–dependent tran-
scriptional activity with increased malonyl-CoA leading to de-
creased promoter activity. These finely tuned malonyl-CoA sensors
paved the way for implementing synthetic metabolic controls and
optimizing the production of malonyl-CoA–derived compounds.
Switching Properties of Integrated Malonyl-CoA Sensors. One cen-
tral goal of synthetic biology is to integrate multiple gene circuits
and achieve dynamic control in living biological systems (41, 42).
The signal-processing capability of integrated circuits is closely
related with the regulatory architecture and dynamics of the
composed circuits (43). As such, integrated synthetic gene cir-
cuits often cannot work properly due to various design faults. For
example, the use of multiple regulators/promoters tends to result
in circuits with mismatched gene expression levels, incoherent
input signal ranges, and delayed time response curves (43, 44). A
functional integrated circuit will require extensive work to iter-
atively tune the responsiveness of the interacting molecules.
By integrating the malonyl-CoA–regulated T7 and pGAP
promoter, we demonstrated that gene expression of two reporter
proteins (eGFP and mCherry) can be exclusively switched be-
tween two distinct states depending on the intracellular level of
malonyl-CoA (Fig. 2). When the level of malonyl-CoA was low,
FapR activated gene expression from the pGAP promoter and
led to increased eGFP signal. At the same time, FapR repressed
gene expression from the T7 promoter and led to a relatively
lower mCherry signal. On the other hand, when the level of
malonyl-CoA was high, malonyl-CoA changed the DNA-binding
affinity of FapR and thus destabilized the transcriptional complex
comprising FapR, RNA polymerase, and the interacting pro-
moters (Fig. 2A). As a result, eGFP expression from pGAP
promoter was deactivated and mCherry expression from the T7
promoter was derepressed, leading to a flip-flopped expression
of eGFP and mCherry (Fig. 2C). When different numbers of
FapR-binding sites (fapO) were inserted into the pGAP-based
circuits (Fig. 2 B–D), gene expression from the integrated circuits
created different switching properties. For example, pGAP pr-
omoter with none (n = 0, Fig. 2B), one (n = 1, Fig. 2C), and three
(n = 3, Fig. 2D) copies of fapO exhibited around 112, 43, and
20% relative promoter activity, respectively, when the T7 pro-
moter switched to half its saturation activity (intracellular
malonyl-CoA concentration is around 0.6 nmol/mgDW).
In contrast to cross-regulation and toggle switches that use
mutually repressible promoters to control gene expression, the
malonyl-CoA switch constructed in this study was composed of
a single regulatory protein (FapR) controlling the expression of
two different promoters (T7 and pGAP) that are transcribed by
different RNA polymerases (T7 RNAP and E. coli RNAP). The
advantage of using a single regulatory protein is that the time
responsiveness and robustness of the system can be improved
and therefore the trivial tweaking and twisting work that is often
required to ensure a functional circuit can be avoided. These
fine-tuned gene-expression switching properties should facilitate
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Fig. 2. Gene expression switching properties of integrated malonyl-CoA
sensors. (A) Schematic representation of the engineered malonyl-CoA
switches consisting of two reporter genes under the control of T7 promoter
and pGAP promoter. Symbols are the same as the symbols in Fig. 1. (B–D)
Switching property of the integrated malonyl-CoA circuits with a different
number of FapR-binding sites (B, n = 0; C, n = 1; D, n = 3). The pGAP relative
promoter activity is calculated based on the promoter activity of each circuit
(n = 0, n = 1, and n = 3) with respect to the saturation promoter activity of
the circuit with one copy of fapO (n = 1). Smooth curves represent dose–
response fitting of the scattered data points.
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the construction of strains with controlled expression of impor-
tant metabolic pathways and efficient biosynthesis of malonyl-
CoA–derived compounds.
Dynamic Pathway Regulation to Improve Fatty Acids Production.We
next sought to implement this malonyl-CoA–dependent meta-
bolic switch to control and optimize fatty acids biosynthesis in
E. coli. For this purpose, the malonyl-CoA source pathway
(acetyl-CoA carboxylase, encoded by accADBC) was placed
under the control of the pGAP promoter and malonyl-CoA sink
pathway (fatty acids synthase, encoded by fabADGI and tesA′)
was placed under the control of the T7 promoter (Fig. 3A).
When malonyl-CoA level is low, FapR activates the transcription
of the malonyl-CoA source pathway and represses the tran-
scription of the malonyl-CoA sink pathway. As a result, malonyl-
CoA is expected to accumulate inside the cell (Fig. 3B). On the
other hand, when malonyl-CoA reaches a critical concentration,
binding of malonyl-CoA to FapR increases the possibility of
FapR dissociation from the interacting promoters. Conse-
quently, transcription of the malonyl-CoA source pathway [ace-
tyl-CoA carboxylase (ACC)] will be turned off and transcription
of the malonyl-CoA sink pathway [fatty acids synthase (FAS)]
will be turned on, leading to increased expression of the malonyl-
CoA sink pathway that converts the accumulated malonyl-CoA
to fatty acids (Fig. 3C).
To validate the above-mentioned control scheme, we experi-
mentally interfaced the synthetic malonyl-CoA switch with the
fatty acids biosynthetic pathway and investigated whether the
proposed control scheme would improve fatty acids production.
Overexpression of either ACC (second column, Fig. 3D) or FAS
(third column, Fig. 3D) pathway led to strains producing around
0.68 and 0.42 g/L of fatty acids, respectively, a 196 and 82.6%
increase compared with the E. coli BL21 wild-type strain (first
column, Fig. 3D). Coupled expression of the malonyl-CoA
source pathway ACC and the malonyl-CoA sink pathway FAS
(fourth column, Fig. 3D) further increased the fatty acids to 1.26
g/L. Insertion of one copy of fapO regulating the ACC pathway
(fifth column, Fig. 3D) moderately decreased the fatty acids pro-
duction, possibly due to the decreased transcriptional activity of
the pGAP promoter when fapO was incorporated (Fig. 1E). The
strains engineered with FapR regulating both the malonyl-CoA
source pathway (ACC) and the malonyl-CoA sink pathway (FAS)
(sixth, seventh, and eighth columns, Fig. 3D) demonstrated re-
markably increased fatty acids production compared with the
strains carrying the uncontrolled ACC and FAS pathway (fourth
column, Fig. 3D). For example, the controlled ACC and FAS
pathway produced around 2.96, 3.86, and 2.63 g/L of fatty acids,
respectively, when none (n = 0, sixth column, Fig. 3D), one (n = 1,
seventh column, Fig. 3D), and three (n = 3, eighth column, Fig. 3D)
copies of fapO were used to regulate the malonyl-CoA source pa-
thway, representing a 1.3, 2.1, and 1.1-fold increase compared with
the uncontrolled metabolic pathway (fourth column, Fig. 3D). The
yield (0.20 g fatty acids/g glucose, 56% of the theoretical yield of the
FA pathway) is comparable with the highest yield (0.28 g fatty acids/g
glucose, 52.4% of the theoretical yield of the β-oxidation reversal
pathway) ever reported (SI Appendix, Table S2). Due to the ex-
pression of cytosolic thioesterase (TesA′), a significant amount of the
carbon flux was redirected to the biosysnthesis of the medium-chain
myristic acid (C14:0) in the engineered strains (SI Appendix,
Fig. S5).
To elucidate how the synthetic malonyl-CoA switch regulates
the fatty acids biosynthesis, we examined cell growth (Fig. 3E)
and intracellular malonyl-CoA (Fig. 3F) in the wild-type strains
and the engineered strains with different numbers of fapO sites
(n = 0, 1, and 3). Not surprisingly, strains with the controlled
FA biosynthetic pathway suffered from a low-cell-growth rate
(0.32 h−1 for n = 0, 0.41 h−1 for n = 1, and 0.45 h−1 for n = 3)
compared with the wild-type strain (0.49 h−1). This largely could
be ascribed to the effects of stress, that is, the expression of
heterologous proteins that deprive essential cellular resources
for maintaining the normal growth rate. When no fapO was used
(n = 0), both the pGAP promoter and the T7 promoter exhibited
relatively higher transcriptional activity (Fig. 2B), leading to in-
creased expression of ACC and FAS. As a result, the cell growth
rate was reduced by 35% from 0.49 to 0.32 h−1.
Interestingly, intracellular malonyl-CoA exhibited an oscilla-
tory changing pattern in the strains carrying the synthetic
malonyl-CoA controller (Fig. 3F), compared with that of the
wild-type strain exhibiting a monotonic decrease at the expo-
nential and stationary phases. The decreased amplitude of the
oscillation indicates the reduced regulating capability of the
malonyl-CoA switch, possibly due to the inhibitory effects asso-
ciated with the accumulation of fatty acids and toxic by-products.
The highest fatty acids production was obtained in the strains
with only one copy of fapO regulating the ACC pathway (sev-
enth column, Fig. 3D), indicating that strains with moderately
A
Mal-CoA source 
pathway (ACC)
Mal-CoA sink 
pathway (FAS)
B
Malonyl-CoA 
pool
Mal-CoA source 
pathway (ACC)
Mal-CoA sink 
pathway (FAS)
C
Fatty 
acids
5 10 15 20 25 30
0.0
0.2
0.4
0.6
0.8
0 5 10 15 20 25 30
0
1
2
3
4
5
6
WT
0 x fapO
1 x fapO
3 x fapO
M
al
-C
oA
 (n
m
ol
/m
gD
W
)
Time (hr)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
E
+
+
+
3
+
+
+
1
+
+
+
0
+
+
--
1
--
+
--
0
+
+
--
0
+
--
--
0
)L/g(
sdica
yttaF
ACC
FAS
FapR
n x fapO
--
--
--
0
WT
0 x fapO
1 x fapO
3 x fapO
F
D
O
D
60
0
Time (hr)
Fig. 3. Dynamic pathway control to improve fatty acids production. (A)
Molecular structure of the constructed malonyl-CoA controller. Malonyl-CoA
source pathway (ACC, encoded by accADBC) was under the control of
malonyl-CoA–downregulated pGAP promoter; malonyl-CoA sink pathway
(FAS, encoded by fabADGI and tesA′) was under the control of malonyl-CoA–
upregulated T7 promoter. Other symbols are the same as the symbols in
Fig. 1. (B) Low level of malonyl-CoA switches on the expression of malonyl-
CoA source pathway (ACC) and switches off the expression of the malonyl-
CoA sink pathway (FAS). (C) High level of malonyl-CoA switches off the
expression of the malonyl-CoA source pathway (ACC) and switches on the
expression of the malonyl-CoA sink pathway (FAS). (D) Implementing dy-
namic malonyl-CoA control to improve fatty acids production. The first col-
umn represents the wild-type strain. All other strains (columns 2–8) carry
a chromosomal mutant version of fadD encoding the fatty acyl-CoA syn-
thetase. The last three columns represent strains carrying the controlled FA
biosynthetic pathway with different numbers of the FapR repressor-binding
site regulating the malonyl-CoA source (ACC) pathway. “n × fapO” denotes
the number of fapO within pGAP-based circuits (n = 0, 1, and 3). (E) Cell
growth curve in the strains carrying the uncontrolled FA biosynthetic path-
way (wild-type strain) and the controlled FA biosynthetic pathway (n = 0, 1,
and 3). Smooth curves represent logistic fitting of the scattered data points.
(F) Intracellular malonyl-CoA profile in the strains carrying the uncontrolled
FA biosynthetic pathway (wild-type strain) and the controlled FA bio-
synthetic pathway (n = 0, 1, and 3).
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oscillating malonyl-CoA pattern (Fig. 3E) could better manage
the trade-off between cell growth and heterologous pathway
expression. Due to the dynamic nature of this system, the “on”
and “off” state of the ACC pathway and the FAS pathway must
be switched at the right time such that the malonyl-CoA con-
sumed by FAS could be efficiently replenished by ACC, and
the malonyl-CoA generated by ACC can be efficiently consumed
by FAS. Not surprisingly, switching the expression of ACC to
FAS too late (n = 0) and too early (n = 3) resulted in relatively
strong and weak malonyl-CoA oscillation and suboptimal fatty acids
production (Figs. 2 and 3F). These results demonstrate that the
engineered strains can dynamically regulate the expression of both
the malonyl-CoA source pathway and the malonyl-CoA sink
pathway and efficiently redirect carbon flux toward FA biosynthesis.
Conclusions.One important synthetic chemistry reaction endowed
by nature is the decarboxylative carbon condensation reaction
using malonyl-CoA as carbon donor (29). Previous metabolic
engineering efforts centered on malonyl-CoA–dependent path-
ways have resulted in the production of many value-added
compounds including fatty acids (21), phenylpropanoids (45, 46),
and polyketides (47). Here we mimicked the native biological
systems and used a dynamic regulatory network to optimize
production titers and yield. In the present work, the naturally
existing transcriptional regulator FapR was rewired to control
the FA biosynthetic pathway of E. coli. Optimal control of gene
expression involved in the supply and consumption of malonyl-CoA
resulted in balanced metabolism between cell growth and product
formation and significantly improved fatty acids production. Ap-
plying this metabolic control allowed the engineered cell to dy-
namically regulate pathway expression and compensated the
metabolic activity of critical enzymes based on the intracellular level
of malonyl-CoA. The synthetic malonyl-CoA switch engineered in
this study opens up new venues for dynamic pathway optimization
and efficient production of malonyl-CoA–derived compounds.
Materials and Methods
Malonyl-CoA Sensor Construction. Synthetic gene fragment fapO-eGFP,
codon-optimized fapR, Discosoma sp mCherry, and custom-designed
pGAP-ePath (SI Appendix, Table S6–S9) were synthesized from IDT or Gen-
Script. pOM vector was a gift by Dr. T. Hueller from Evonik Degussa GmbH
(Creavis Technologies & Innovation, Marl, Germany) (SI Appendix, Table S5).
To construct T7-based malonyl-CoA sensor, eGFP or fapO-eGFP were cloned
into vector pETM9 (30) to give construct pETM9-eGFP or pETM9-fapO-
eGFP. mCherry was inserted into pETM9-fapO-eGFP in place of eGFP to
give pETM9-fapO-mCherry. Then the fapO-mCherry gene fragment from
pETM9-fapO-mCherry was cloned into pCDM4 using restriction sites AvrII
and KpnI to give construct pCDM4-fapO-mCherry. Codon-optimized fapR
was subcloned into pACM4 and pCDM4 using restriction sites NdeI and XhoI
to give construct pACM4-fapR and pCDM4-fapR.
To construct the pGAP-based malonyl-CoA sensor, eGFP from pIDTBlue-
fapO-eGFP was subcloned into pOM to give pOM-0×fapO-eGFP using re-
striction sites XbaI and HindIII. Then fapO-eGFP was subcloned into pBAD24
using restriction sites NheI and HindIII to give pBAD24-1×fapO-eGFP. Due to
the internal XbaI site in front of eGFP, multiple copies of fapO were inserted
by iteratively ligating the XbaI/HindIII-digested recipient vector (i.e.,
pBAD24-m×fapO-eGFP) and the NheI/HindIII-digested donor vector (i.e.,
pBAD24-n×fapO-eGFP) to give the construct pBAD24-(m+n)×fapO-eGFP.
Then the n×fapO-eGFP gene fragment from pBAD24-n×fapO-eGFP was
subcloned into pOM to give pOM-n×fapO-eGFP (n = 0, 1, 2, 3, 5, 8, 13, and
21) using restriction sites NheI/HindIII and XbaI/HindIII. To eliminate the UAS
sequence, an additional SalI site in front of the pGAP promoter was inserted
into pOM-fapO-eGFP by Quickchange II site-directed mutagenesis kits using
primer pairs SalI_pOMF and SalI_pOMR. Then the SalI single-digested pOM-
fapO-eGFP was self-ligated to give construct pOM0-fapO-eGFP. All clones
were screened by restriction digestion analysis and verified by gene
sequencing.
FAS and ACC Pathway Construction. To construct FAS pathway, E. coli tesA′,
fabA, fabD, fabG, and fabI gene fragments were assembled into artificial
operon form based on the ePathBrick gene assembly platform (48). Briefly,
the XbaI/SalI-digested donor vector was ligated to the SpeI/SalI-digested
recipient vector to give an operon gene configuration. The resulting syn-
thetic operon containing tesA′-fabADGI was cloned into pETM9-fapO-eGFP
in place of eGFP with an XbaI/SalI digest. Then, the tesA′-fabADGI gene
fragment from pETM9-fapO-FAS was cloned into pRSM3 vector to give
pRSM4-fapO-FAS using restriction sites AvrII and SalI.
The synthetic gene fragment containing UAS, pGAP promoter, ePathBrick
restriction sites, and rrnB terminator (SI Appendix, Table S9) was cloned into
pETM6 to give pXPA vector using restriction sites ApaI and SalI. Then eGFP,
1×fapO-eGFP, and 3×fapO-eGFP from pBAD24-n×fapO-eGFP (n = 0, 1, and 3)
were subcloned into pXPA vector using restriction sites XbaI/KpnI and NheI/KpnI,
yielding vectors pXPA-eGFP, pXPA-1×fapO-eGFP, and pXPA-3×fapO-eGFP. To
construct the ACC pathway, E. coli accA, accD, accB, and accC gene fragments
were assembled into an artificial operon form based on the ePathBrick gene
assembly platform (48). Next, the eGFP fragment in pXPA-eGFP, pXPA-1×fapO-
eGFP, and pXPA-3×fapO-eGFP was replaced by the synthetic operon containing
accADBC with an XbaI/SalI digest, yielding vectors pXPA-ACC, pXPA-1×fapO-
ACC, and pXPA-3×fapO-ACC, respectively. All clones were screened by restriction
digestion analysis and verified by gene sequencing.
Sensor Activity Assay. Fluorescence intensity was used to characterize the
promoter activity among the engineered sensors. Host cell BL21*(DE3)
transformed with different sensor plasmids was grown overnight in LB at
37 °C and 250 × g. The next morning, 10 mL fresh LB was inoculated with 8%
(vol/vol) overnight culture in 50-mL Corning tubes and grown at 37 °C with
shaking at 250 × g for ∼1 h (OD of 0.2 in a 96-well plate). Cell culture (240 μL)
was transferred to a Greiner Bio-one 96-well fluorescence plate (Bio-
Greiner). Different amounts of isopropyl β-D-1-thiogalactopyranoside (IPTG)
and cerulenin were added to the cell culture to induce the expression of
FapR and stimulate the level of malonyl-CoA. The fluorescence plates were
covered and sealed with parafilm to prevent evaporation. Cells were left to
grow at 37 °C with shaking at 300 × g on a benchtop plate shaker (Labnet
VorTemp 56 shaker incubator). Cell optical density and expression of fluo-
rescence protein (eGFP and mCherry) were simultaneously detected every 30
or 45 min using a Biotek Synergy 4 microplate reader. Optical density was read
at 600 nm. For measurement of only eGFP signal, a Tungsten light source with
monochrome filter (excitation: 485 ± 20 nm; emission: 528 ± 20 nm) was used.
For measurement of both eGFP and mCherry, Xenon light source was used; the
excitation and emission wavelength settings for eGFP and mCherry were 470/
510 and 580/620 nm, respectively. All experiments were performed in triplicates.
Fatty Acids Fed-Batch Fermentation. Fed-batch scale fermentation was per-
formed with a 2-L stirred tank bioreactor. Fresh cells from agar plates were
used to inoculate 50 mL MK media [13.5 g/L KH2PO4, 4.0 g/L (NH4)2HPO4,
1.7 g/L citric acid, 20 g/L glucose, 10 g/L yeast extract, and 10 mL/L trace
metals (21) with pH adjusted to 6.8 by sodium hydroxide] with appropriate
antibiotics in 250-mL shake flasks and allowed to grow at 37 °C for 20 h.
Exponentially growing cells from the overnight culture were inoculated to
the bioreactor containing 1.2 L of MK media with an initial OD of 0.08. The
bioreactor was run at a fixed oxygen concentration (30% saturation) and
37 °C with aeration rate at 1.5 vvm. Induction of FapR expression was per-
formed by adding 100 μM IPTG, and the cultivation temperature was
switched to 33 °C at 6 h of fermentation (OD = 5). Ten milliliters of 40%
glucose was pulsed into the bioreactor at 20 and 32 h after the start of the
fermentation. Samples were taken at the end of the fermentation (44 h) and
subjected to fatty acids extraction and analysis. Bioreactor experiments were
performed in duplicates.
Fatty Acids and Malonyl-CoA Quantification. Total fatty acids were extracted
using a modified protocol reported by Voelker (49). Briefly, 0.4 mL of culture
was acidified with 40 μL of acetic acid, spiked with 5 μL of 10 mg/mL pen-
tadecanoic acid as an internal standard, and partitioned with 750 μL of
CHCl3-CH3OH (2:1 by volume) at room temperature. The extraction was
performed with a VWR high-duty vortex platform at 1,600 × g for 1 h. After
a brief centrifugation, 400 μL of lower-phase chloroform was transferred to
Eppendorf tubes and evaporated to dryness with a Vacufuge. The resulting
crude fatty acids were redissolved in 400 μL 5% (vol/vol) H2SO4 in methanol
and incubated in a sealed vial at 60 °C for 2 h. Four hundred microliters of
0.9% NaCl was added to the reaction mixture, and the resulting fatty acid
methyl esters (FAMEs) were extracted with 250 μL of hexane. Gas chroma-
tography analysis of FAMEs was performed with a Bruker GC-450 equipped
with a Flame ionization detector and a capillary column HP-INNOWAX (30 m ×
0.25 mm), following the procedures reported by Tai (10).
For malonyl-CoA quantification, E. coli cell culture (around 40 OD units)
was chilled in ice and centrifuged at 4,500 × g and 4 °C for 15 min. Cell pellet
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was then frozen with liquid nitrogen and homogenized with mortar and
pestle in 2.0 mL 6% prechilled perchloric acid supplemented with 0.5 μg/mL
[13C3]-malonyl-CoA as internal standard. After centrifugation at 4,500 × g
and 4 °C for 15 min, the supernatant was loaded to a Waters solid-phase
extraction column to remove salt and concentrate malonyl-CoA. Then the
elute was subjected to liquid chromatography–mass spectrometry analysis to
determine the intracellular levels of malonyl-CoA following the procedure
described by Onorato (50).
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